Know Cancer

or
forgot password
  • cancer clinical trials in north adams, MA

  • A Study Of Oral PF-02341066, A c-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer
    Pfizer Investigational Site
    North Adams, Massachusetts 01247
    Systemic Anaplastic Large-Cell Lymphoma, Neoplasms, Anaplastic Lymphoma Kinase, Human, NSCLC
    BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab
    Berkshire Hematology Oncology, P.C.-North Adams
    North Adams, Massachusetts 01247
    Breast Cancer
    Prospective Observational Epidemiologic Study of Maraviroc's Safety
    Pfizer Investigational Site
    North Adams, Massachusetts 01247
    Human Immunodeficiency Virus
    Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer
    Pfizer Investigational Site
    North Adams, Massachusetts 01247
    Kidney Neoplasms
    PF-00299804 As A Single Oral Agent In Selected Patients With Adenocarcinoma Of The Lung
    Pfizer Investigational Site
    North Adams, Massachusetts 01247
    Carcinoma, Non-small Cell
    Axitinib (AG-013736) With Or Without Dose Titration (Increase) In Patients With Kidney Cancer
    Pfizer Investigational Site
    North Adams, Massachusetts 01247
    Carcinoma, Renal Cell
    A Trial In Patients With Advanced Cancer And Leukemia
    Pfizer Investigational Site
    North Adams, Massachusetts 01247
    Neoplasms by Histologic Type
    Study Evaluating The Effects Of Neratinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer
    Pfizer Investigational Site
    North Adams, Massachusetts 01247
    Breast Cancer
    A Study Of Combined C- MET Inhibitor And PAN-HER Inhibitor (PF-02341066 And PF-00299804) In Patients With Non- Small Cell Lung Cancer
    Pfizer Investigational Site
    North Adams, Massachusetts 01247
    Non Small Cell Lung Cancer
    ARCHER 1009 : A Study Of PF-00299804 (Dacomitinib) Vs. Erlotinib In The Treatment Of Advanced Non-Small Cell Lung Cancer
    Pfizer Investigational Site
    North Adams, Massachusetts 01247
    Non-Small Cell Lung Cancer (NSCLC)
    Study Evaluating Inotuzumab Ozogamicin In Acute Lymphocytic Leukemia
    Pfizer Investigational Site
    North Adams, Massachusetts 01247
    Acute Lymphocytic Leukemia
    A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer
    Pfizer Investigational Site
    North Adams, Massachusetts 01247
    Endometrial Neoplasms
    A Study To Evaluate PF-04449913 With Chemotherapy In Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
    Pfizer Investigational Site
    North Adams, Massachusetts 01247
    Acute Myeloid Leukemia
    Randomized Trial Of Exemestane Versus Continued Tamoxifen In Postmenopausal Women With Early Breast Cancer
    Pfizer Investigational Site
    North Adams, Massachusetts 01247
    Breast Neoplasms
    A Phase II Study of CI-1033 in Treating Patients With Metastatic (Stage IV) Breast Cancer
    Pfizer Investigational Site
    North Adams, Massachusetts 01247
    Breast Neoplasms
    Study of the Safety and Efficacy of SU-011,248 in Adult Patients With Advanced Kidney Cancer
    Pfizer Investigational Site
    North Adams, Massachusetts 01247
    Kidney Neoplasms
    Treatment With SU11248 in Patients With Neuroendocrine Tumors
    Pfizer Investigational Site
    North Adams, Massachusetts 01247
    Neuroendocrine Tumors
    Study Evaluating Interferon And CCI-779 In Advanced Renal Cell Carcinoma
    Pfizer Investigational Site
    North Adams, Massachusetts 01247
    Carcinoma, Renal Cell, Kidney Neoplasms
    A Clinical Efficacy Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 Given In Combination With Chemotherapy
    Pfizer Investigational Site
    North Adams, Massachusetts 01247
    Lung Neoplasms
    Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 To Treat Small-Volume Ovarian, Peritoneal, Fallopian Tube Cancer
    Pfizer Investigational Site
    North Adams, Massachusetts 01247
    Ovarian Neoplasms, Peritoneal Neoplasms, Fallopian Tube Neoplasms
    A Study To Assess The Safety And Efficacy Of SU11248 In Patients With Gastrointestinal Stromal Tumor(GIST)
    Pfizer Investigational Site
    North Adams, Massachusetts 01247
    Gastrointestinal Stromal Tumor
    Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Renal Cell Carcinoma
    Pfizer Investigational Site
    North Adams, Massachusetts 01247
    Kidney Neoplasms
    AG-013736 In Combination With Docetaxel Versus Docetaxel Alone For Patients With Metastatic Breast Cancer
    Pfizer Investigational Site
    North Adams, Massachusetts 01247
    Breast Neoplasms
    A Pivotal Study Of SU011248 In The Treatment Of Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma.
    Pfizer Investigational Site
    North Adams, Massachusetts 01247
    Carcinoma, Renal Cell
    A Study of SU11248 In Patients With Metastatic Breast Cancer Who Have Failed Selected Other Therapies.
    Pfizer Investigational Site
    North Adams, Massachusetts 01247
    Breast Neoplasms
    SU011248 Versus Interferon-Alfa As First-Line Systemic Therapy For Patients With Metastatic Renal Cell Carcinoma
    Pfizer Investigational Site
    North Adams, Massachusetts 01247
    Carcinoma, Renal Cell
    SU011248 In The Treatment Of Patients With Bevacizumab (Avastin)-Refractory Metastatic Renal Cell Carcinoma
    Pfizer Investigational Site
    North Adams, Massachusetts 01247
    Carcinoma, Renal Cell
    A Treatment Protocol for Patients With Gastrointestinal Stromal Tumor (GIST) Who May Derive Benefit From Treatment With SU011248
    Pfizer Investigational Site
    North Adams, Massachusetts 01247
    Gastrointestinal Neoplasm
    Anti-Angiogenesis Agent AG-013736 In Patients With Metastatic Melanoma
    Pfizer Investigational Site
    North Adams, Massachusetts 01247
    Melanoma, Skin Neoplasms
    Trial Of Irinotecan In Combination With Three Methods Of Administration Of Fluoropyrimidine.
    Pfizer Investigational Site
    North Adams, Massachusetts 01247
    Colorectal Neoplasms
    Study Evaluating Biomarkers In Relapsed/Refractory Pediatric Solid Tumors
    Pfizer Investigational Site
    North Adams, Massachusetts 01247
    Adenocarcinoma, Neoplasms
    Treatment Use Study With Sunitinib (SU011248) For Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma
    Pfizer Investigational Site
    North Adams, Massachusetts 01247
    Carcinoma, Renal Cell
    Study Of SU011248 Administered On A Continuous Daily Dosing Schedule In Patients With Gastrointestinal Stromal Tumor
    Pfizer Investigational Site
    North Adams, Massachusetts 01247
    Gastrointestinal Stromal Tumors
    Pharmacogenomics Blood Sampling Protocol For Irinotecan/Fluorouracil/Leucovorin(CPT-11/FU/LV).
    Pfizer Investigational Site
    North Adams, Massachusetts 01247
    Colorectal Neoplasms
    Adjuvant Epirubicin/Cytoxan Followed By A Taxane VS. Epirubicin/Taxane As Treatment For Node-Positive Breast Cancer
    Pfizer Investigational Site
    North Adams, Massachusetts 01247
    Adenocarcinoma
    A Phase 1 Study Of An Intravenously Administered Cyclin-Dependent Kinase Inhibitor In Patients With Advanced Cancer
    Pfizer Investigational Site
    North Adams, Massachusetts 01247
    Neoplasms, Lymphoma, Non-Hodgkin
    Study Evaluating Bazedoxifene Acetate In Osteoporosis In Postmenopausal Women
    Pfizer Investigational Site
    North Adams, Massachusetts 01247
    Osteoporosis
    Trial of Paclitaxel/Carboplatin + PF-3512676 vs Paclitaxel/Carboplatin Alone in Patients With Advanced Non-Small Cell Lung Cancer
    Pfizer Investigational Site
    North Adams, Massachusetts 01247
    Carcinoma, Non-Small-Cell Lung
    Study Evaluating the Safety Of HKI-272 (Neratinib) In Subjects With Advanced Non-Small Cell Lung Cancer
    Pfizer Investigational Site
    North Adams, Massachusetts 01247
    Carcinoma, Non-Small-Cell Lung, Lung Neoplasms
    A Study Of SU011248 Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel In Patients With Advanced Breast Cancer
    Pfizer Investigational Site
    North Adams, Massachusetts 01247
    Breast Neoplasms
    Study Of AG-013736 In Patients With 131I-Refractory Thyroid Cancer
    Pfizer Investigational Site
    North Adams, Massachusetts 01247
    Thyroid Neoplasms
    Expanded Access Program for Maraviroc At Multiple Centers
    Pfizer Investigational Site
    North Adams, Massachusetts 01247
    Advanced HIV Infection
    A Study Of Sunitinib Compared To Placebo For Patients With Advanced Pancreatic Islet Cell Tumors
    Pfizer Investigational Site
    North Adams, Massachusetts 01247
    Carcinoma, Islet Cell, Carcinoma, Pancreas
    Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer.
    Pfizer Investigational Site
    North Adams, Massachusetts 01247
    Carcinoma, Pancreatic Ductal
    PF-00299804 As A Single Agent, In Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Chemotherapy And Erlotinib
    Pfizer Investigational Site
    North Adams, Massachusetts 01247
    Carcinoma, Non Small Cell Lung
    Study Of CP-751,871 In Patients With Ewing's Sarcoma Family Of Tumors
    Pfizer Investigational Site
    North Adams, Massachusetts 01247
    Ewing's Sarcoma Family of Tumors
    Carboplatin And Paclitaxel With Or Without CP-751, 871 (An IGF-1R Inhibitor) For Advanced NSCLC Of Squamous, Large Cell And Adenosquamous Carcinoma Histology
    Pfizer Investigational Site
    North Adams, Massachusetts 01247
    Carcinoma, Squamous Cell, Carcinoma, Adenosquamous, Carcinoma, Large Cell, Carcinoma, Non-Small-Cell Lung
    A Study Of AG-013736 (Axitinib) Or Bevacizumab (Avastin) In Combination With Paclitaxel And Carboplatin In Patients With Advanced Lung Cancer.
    Pfizer Investigational Site
    North Adams, Massachusetts 01247
    Non-Small-Cell Lung Carcinoma, Adenocarcinoma
    A Study of PF-04217903 in Patients With Advanced Cancer
    Pfizer Investigational Site
    North Adams, Massachusetts 01247
    Neoplasms
    Follow-Up Study for Exubera
    Pfizer Investigational Site
    North Adams, Massachusetts 01247
    Diabetes Mellitus
    A Study Of PF-04554878 In Patients With Advanced Non-Hematologic Malignancies
    Pfizer Investigational Site
    North Adams, Massachusetts 01247
    Cancer
    Study Evaluating Bosutinib-Exemestane Combination Vs Exemestane Alone in Post Menopausal Women With Breast Cancer
    Pfizer Investigational Site
    North Adams, Massachusetts 01247
    Advanced Breast Cancer
    Rollover Protocol for Prior SU011248 Protocols
    Pfizer Investigational Site
    North Adams, Massachusetts 01247
    Solid Tumors
    Study Evaluating Inotuzumab Ozogamicin (CMC-544) Plus Rituximab In Diffuse Large B-Cell Non-Hodgkin's Lymphoma
    Pfizer Investigational Site
    North Adams, Massachusetts 01247
    Lymphoma, B-Cell
    Study of PF-05212384 (Also Known as PKI-587)Administered Intravenously To Subjects With Solid Tumors
    Pfizer Investigational Site
    North Adams, Massachusetts 01247
    Neoplasms
    Study Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast Cancer
    Pfizer Investigational Site
    North Adams, Massachusetts 01247
    Advanced Breast Cancer (Parts 1 and 2), Advanced Pancreatic Cancer (Part 1), Advanced Colorectal Cancer (Part 1), Advanced Cholangiocarcinoma (Part 1), Advanced Glioblastoma Multiforme (Part 1)
    Retrospective Observational Study To Update 5-Year Survival Of Subjects Who Participated In Axitinib Trial A4061012
    Pfizer Investigational Site
    North Adams, Massachusetts 01247
    Carcinoma, Renal Cell
    A Study Of PF-04449913 Administered Alone In Select Solid Tumors
    Pfizer Investigational Site
    North Adams, Massachusetts 01247
    Solid Tumors
    CP-751,871 Treatment For Patients With Multiple Myeloma
    Pfizer Investigational Site
    North Adams, Massachusetts 01247
    Multiple Myeloma